Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Xymogen Launches Pharmaceutix Medical Foods and Partners With Acasti Pharma - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Xymogen Launches Pharmaceutix Medical Foods and Partners With Acasti Pharma

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Xymogen, Orlando, FL, has announced an exclusive partnership with Canada-based Acasti Pharma, with whom they will launch the worldwide distribution of LipiChol540, a physician-prescribed medical food to manage omega 3 phospholipid deficiency. The formula will be distributed by Pharmaceutix Medical Foods, a wholly owned subsidiary of Xymogen. Acasti’s focus is in the medical use of long-chain omega 3 phospholipids for treatment of chronic cardiovascular and cardiometabolic disorders. LipiChol540 contains high levels of omega 3 essential fatty acids and antioxidants and has become known as a nutrient-rich “superfood” because it is more easily absorbed into the body than fish oil.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics